Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Monson

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growthW M Drake, P V Carroll, K T Maher, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumorsK Lidhar, M Korbonits, S Jordan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2006
A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiencyA M Brooke, N F Taylor, J H Shepherd, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumorsG Kaltsas, M Korbonits, E Heintz, et al.
European Journal of Endocrinology|November 30, 2006
Selective parathyroid venous sampling in patients with complicated hyperparathyroidismC M Ogilvie, P L Brown, M Matson, et al.
Clinical Endocrinology|April 25, 2001
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegalyF Miraki-Moud, P J Jenkins, P D Fairclough, et al.
Clinical Endocrinology|April 18, 2003
Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiencyJ Svensson, J P Monson, T Vetter, et al.
European Journal of Endocrinology|December 3, 2009
Diagnosis, management and therapeutic outcome in prepubertal Cushing's diseaseR P Dias, A Kumaran, L F Chan, et al.
Clinical Endocrinology|April 18, 2007
Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrationsC C Dupuis, H L Storr, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activityG A Kaltsas, A M Isidori, D Florakis, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growthW M Drake, P V Carroll, K T Maher, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumorsK Lidhar, M Korbonits, S Jordan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2006
A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiencyA M Brooke, N F Taylor, J H Shepherd, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumorsG Kaltsas, M Korbonits, E Heintz, et al.
European Journal of Endocrinology|November 30, 2006
Selective parathyroid venous sampling in patients with complicated hyperparathyroidismC M Ogilvie, P L Brown, M Matson, et al.
Clinical Endocrinology|April 25, 2001
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegalyF Miraki-Moud, P J Jenkins, P D Fairclough, et al.
Clinical Endocrinology|April 18, 2003
Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiencyJ Svensson, J P Monson, T Vetter, et al.
European Journal of Endocrinology|December 3, 2009
Diagnosis, management and therapeutic outcome in prepubertal Cushing's diseaseR P Dias, A Kumaran, L F Chan, et al.
Clinical Endocrinology|April 18, 2007
Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrationsC C Dupuis, H L Storr, L A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activityG A Kaltsas, A M Isidori, D Florakis, et al.
Pageof 18